滚动资讯
FierceBiotechWCG acquires The Contract Network in bid to streamline clinical trial executionFierceBiotech在特朗普政府推动迷幻药政策的背景下，Compass和Usona获得FDA国家优先审查券BioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-April 23, 2026FierceBiotech木马游戏——赫鲁斯上任两月后更换CEO，为科学委员会增添经验FierceBiotechAfter Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?BioWorldIn the clinic for April 24, 2026BioWorldOther news to note for April 24, 2026BioWorldRegulatory actions for April 24, 2026PLoS BiologyA cortico-subthalamic circuit rapidly engages and releases inhibition of specific movements depending on the environmental contextPLoS BiologyA mother’s gift: Provisioning of plastid-derived structures into eggs promotes invertebrate development and dispersalPLoS BiologyEmergent spatial structure in the gut microbiota is driven by bacterial growth and gut contractions
BioWorld 2025年12月10日

D3 Bio完成1.08亿美元B轮融资，推进KRAS G12C进入三期临床试验。

D3 Bio完成1.08亿美元B轮融资，推进KRAS G12C进入三期临床试验。

原文
暂时没有全文，请查看原始来源。